Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


Oncology Clinical Development Congress

10 Oct 2012 - 11 Oct 2012 - Manchester, UK



Bookmark and Share


The global oncology market faces the dual problem of increasing drug development expenses and the high failure rate of oncology drugs. The current ROI in drug development has been estimated to be as low as 0.3%. As experts try to reduce expenses and increase their chances of success, the industry is witnessing an increased emphasis on early decision making, adaptive programme design and strategic clinical alliances.

Over the 2 days, the Oncology Clinical Development Congress will provide a high-level platform for discussing these challenges and hearing case studies from those who have taken great steps in overcoming them. The conference programme consists of 20 world-class keynote addresses, industry and academic led presentations and panel debates, creating an interactive forum for scientific and business debate.

Over the two days, key opinion leaders will explore pioneering solutions and critical opportunities in areas such as targeted therapeutics, clinical imaging and operations management. On Day 1, our internationally recognised experts will discuss strategies for co-developing combined therapies, establishing clear endpoints and building successful clinical partnerships. On Day 2, delegates will hear from those working at the forefront of trial design, patient selection and clinical outsourcing.



Further information
Scientific News
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Genetic Diversity of Enzymes Alters Metabolic Individuality
ToMMo scientists have shown that genetic polymorphisms, structural location of mutation and effect for phenotype correlate with each other.
IMM Uses Nanowizard® to Evaluate Cardiovascular Disease Risk
JPK Instruments reports on the use of their NanoWizard® AFM system at the Instituto de Medicina Molecular at the University of Lisbon.
$1M NIH Grant to Refine PCR Based Cancer Test
Researchers at Cornell University, Weill Cornell Medicine, the University of California, San Francisco, and the Infectious Diseases Institute in Kampala, Uganda, recieve a four-year, $1 million grant to hone technology for a quick, in-the-field diagnosis of Kaposi's sarcoma — a cancer frequently related to HIV infections.
Zika Reference Strain Sequenced
An international research team has sequenced a strain of Zika for use as a WHO reference strain.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!